0001104659-18-059112.txt : 20180927
0001104659-18-059112.hdr.sgml : 20180927
20180927163103
ACCESSION NUMBER: 0001104659-18-059112
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180924
FILED AS OF DATE: 20180927
DATE AS OF CHANGE: 20180927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andrews Kurt J.
CENTRAL INDEX KEY: 0001636133
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 181091290
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
3
1
a3.xml
3
X0206
3
2018-09-24
0
0000722830
IMMUNOMEDICS INC
IMMU
0001636133
Andrews Kurt J.
C/O IMMUNOMEDICS
300 THE AMERICAN ROAD
MORRIS PLAINS
NJ
07950
0
1
0
0
CHIEF HUMAN RESOURCES OFFICER
Stock Option (right to buy)
24.76
2019-07-11
2025-07-11
Common Stock, par value $0.01 per share
76222
D
The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter.
On September 24, 2018, the Issuer appointed the Reporting Person as the Issuer's Chief Human Resources Officer.
/s/ Kurt Andrews
2018-09-27